Mitochondrial metabolism in laryngeal cancer: therapeutic mechanisms and prospects
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2025
DOI: 10.1016/j.bbcan.2025.189335 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025. Verfasst von Yun-Jing Hou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Harbin Medical University, Harbin, China; Harbin Medical University Cancer Hospital, Harbin, China; Department of Precision Medicine Center, Harbin M…. Hauptthemen laut MEDLINE: Laryngeal Neoplasms, Mitochondria. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 173 Literaturangaben. Gefördert von: Wu Jieping Medical Foundation, National Natural Science Foundation of China, Harbin Medical University.
Abstract (Originalsprache)
Tumours reprogram pathways that regulate nutrient uptake and metabolism to meet the biosynthetic, bioenergetic, and redox requirements of cancer cells. This phenomenon is known as metabolic reprogramming and is edited by the deletion of oncogenes and the activation of proto-oncogenes. This article highlights the pathological mechanisms associated with metabolic reprogramming in laryngeal cancer (LC), including enhanced glycolysis, tricarboxylic acid cycle, nucleotide synthesis, lipid synthesis and metabolism, and amino acid metabolism, with a special emphasis on glutamine, tryptophan, and arginine metabolism. All these changes are regulated by HPV infection, hypoxia, and metabolic mediators in the tumour microenvironment. We analyzed the function of metabolic reprogramming in the development of drug resistance during standard LC treatment, which is challenging. In addition, we revealed recent advances in targeting metabolic strategies, assessing the strengths and weaknesses of clinical trials and treatment programs to attack resistance. This review summarises some currently important biomarkers and lays the foundation for therapeutic pathways in LC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Harbin Medical University, Harbin, China; Harbin Medical University Cancer Hospital, Harbin, China; Department of Precision Medicine Center, Harbin Medical University Cancer Hospital, Harbin, China.
- Harbin Medical University, Harbin, China; Harbin Medical University Cancer Hospital, Harbin, China; Department of Pathology, Harbin Medical University Cancer Hospital, Harbin, China. Electronic address: menghongxue@hrbm…
Förderung
- Wu Jieping Medical Foundation
- National Natural Science Foundation of China
- Harbin Medical University
- Natural Science Foundation of Heilongjiang Province
Zitieren
APA
Hou, Y. J., Yang, X. X., & Meng, H. X. (2025). Mitochondrial metabolism in laryngeal cancer: therapeutic mechanisms and prospects. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2025.189335
Vancouver
Hou YJ, Yang XX, Meng HX. Mitochondrial metabolism in laryngeal cancer: therapeutic mechanisms and prospects. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2025. doi:10.1016/j.bbcan.2025.189335
BibTeX
@article{Hou2025,
author = {Hou, Yun-Jing and Yang, Xin-Xin and Meng, Hong-Xue},
title = {Mitochondrial metabolism in laryngeal cancer: therapeutic mechanisms and prospects},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2025},
doi = {10.1016/j.bbcan.2025.189335}
}
EUVIMED